robert j. matheis, phd, ma executive director, global scientific communications celgene corp....

17
Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of HEOR Strategic Plan Past President, International Society for Medical Publication Professionals (ISMPP)

Upload: christina-washington

Post on 28-Dec-2015

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Robert J. Matheis, PhD, MAExecutive Director, Global Scientific Communications Celgene Corp.

Integrating Communication/Publication Strategy as Part of HEOR Strategic Plan

Past President, International Society for Medical Publication Professionals (ISMPP)

Page 4: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

In the beginning. . .

• Providers were healthcare decision makers

• Provider decisions primarily determined access to medicine

• We aimed to inform physicians on research, education, and communication

Why is integration Important?

Page 5: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Why is integration Important?

Page 6: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Why is integration Important?

Healthcare (globally) costs are unsustainably high.

We don’t have the resources to manage costs and needs.

There are many stakeholders in today’s healthcare environment.

There is no room for error.

Page 7: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Why is integration Important?

Scientific and Medical Evidence Support Optimal Treatment Decisions and

Product Access

It’s all about communication.

Page 11: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Clinical Plan

HEOR/Market Access Plan

Point 3: Value proposition is not additive it is integrative.

What are best practices?

Page 13: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

There are many tools available.

What are best practices?

Point 5: Know your location in the evidence continuum. Select the right tools for the right need.

Page 14: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Collaborate. The “Book Ends.”

What are best practices?

Point 6: Capabilities must work together.

Identify gap

Generate Data

Write

Publish

Page 16: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Five items to take with you.

What can I do Today?

1. Start with the end in mind. Ask BIG questions.

2. Communicate with EVERYONE. Make your intentions clear.

3. Develop science and EDUCATION not projects.

4. Remember the “book ends”. Research and publish to fill GAPS.

5. Don’t forget the PATIENT. They are payers too!

Page 17: Robert J. Matheis, PhD, MA Executive Director, Global Scientific Communications Celgene Corp. Integrating Communication/Publication Strategy as Part of

Thank you.

What questions do you have for me?

Robert J. Matheis, PhD, MAExecutive Director, Global Scientific Communications Celgene Corp.Past President, International Society for Medical Publication Professionals (ISMPP)